Longboard Pharmaceuticals Inc (LBPH) - News Archive

Lundbeck s Strategic Acquisition of Longboard Pharmaceuticals: A Pivotal Move in the Neuroscience Arena In a landmark transaction poised to significantly enhance its neuroscience pipeline, the Danish pharmaceutical gian...

Longboard Pharmaceuticals Advances in Neurological Drug Development: Phase 3 DEEp SEA Study Initiated for BexicaserinLongboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company, has announ...

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a biopharmaceutical company specializing in neurological disease therapies, has recently achieved significant regulatory milestones for its investigational drug, bexicaser...

Longboard Pharmaceuticals Reports Promising Interim Results for Bexicaserin in Treating Developmental and Epileptic Encephalopathies La Jolla, Calif. Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biop...

Longboard Pharmaceuticals Inc (LBPH) Stock Is Emerging from the CloudsIn recent news, Longboard Pharmaceuticals Inc (NASDAQ:LBPH) has been making waves in the stock market. Cantor Fitzgerald, a renowned financial servic...

In the world of biopharmaceuticals, Longboard Pharmaceuticals Inc. (LBPH) is making strong strides. With recent developments and positive analyst opinions, LBPH has emerged as a top choice for investors looking for a su...

The American Association of Kidney Patients (AAKP) marked this year s Independence Day celebration by announcing the remarkable success and growing impact of their non-partisan KidneyVoter™ registration drive. This init...

Longboard Pharmaceuticals, a leading clinical-stage biopharmaceutical company specializing in innovative treatments for neurological diseases, has recently announced that its investigational drug, bexicaserin, has been...

Longboard Pharmaceuticals Inc (LBPH) is a clinical-stage biopharmaceutical company that focuses on the development of innovative medicines for neurological diseases. In recent weeks, LBPH shares have experienced mixed p...

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), known for its novel and transformative medicines for neurological diseases, unveiled its first quarter 2024 results, demonstrating strong financial health and significant...